Back
Nautilus Biotechnology, Inc. 10K Form
Sell
36
NAUT
Nautilus Biotechnology, Inc.
Last Price:
$2.01
Seasonality Move:
-17.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NAUT News And Ratings
See the #1 stock for the next 7 days that we like better than NAUT
NAUT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-11.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.34 |
| Price / Book: | 1.52 |
Profitability
| EPS (TTM): | -0.49820 |
|---|---|
| Net Income (TTM): | $-62.8M |
| Gross Margin: | $-6.4M |
| Return on Equity: | -32.15% |
| Return on Assets: | -27.45% |
Nautilus Biotechnology, Inc. Earnings Forecast
Key Nautilus Biotechnology, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Nautilus Biotechnology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | NAUT |
| Website: | nautilus.bio |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 14.95 |
| Quick Ratio: | 14.63 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NAUT Technical Analysis vs Fundamental Analysis
Sell
36
Nautilus Biotechnology, Inc. (NAUT)
is a Sell
Is Nautilus Biotechnology, Inc. a Buy or a Sell?
-
Nautilus Biotechnology, Inc. stock is rated a SellThe current Nautilus Biotechnology, Inc. [NAUT] share price is $2.03. The Score for NAUT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.